Bridging Metabolism and Neurodegeneration: Antidiabetic Drugs as Therapeutics for Parkinson’s Disease
International Journal of High School Research · 31.05.2026 · 8 (9) · 182-192
DOI: 10.36838/ijhsr89.182 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of High School Research, online erschienen am 31.05.2026. Verfasst von Jeffrey Winoto.
Abstract (Originalsprache)
Neurodegenerative and metabolic disorders were historically studied in isolation, but there is growing evidence in recent years that suggests they are more interconnected than originally thought.This review looks at Parkinson's Disease (PD), the world's second most common neurodegenerative disease, and Type 2 Diabetes Mellitus (T2DM), a widespread metabolic disease.Both disorders predominantly affect older populations and share astonishingly similar pathologies and mechanisms.Recent studies have begun to explain their comorbidity not as a coincidence, but as a consequence of the interconnected nature of metabolic and neurodegenerative disorders.This review explores their overlaps to improve the understanding of T2DM and PD and the current cross-treatment approach for both conditions.The shared core dysfunctions of PD and T2DM not only link the two diseases but also offer cross-treatment potential.Ultimately, this overlap is crucial in introducing new therapeutic opportunities and guiding research to more integrated, effective cross-treatment strategies in the future.
Zitieren
APA
Winoto, J. (2026). Bridging Metabolism and Neurodegeneration: Antidiabetic Drugs as Therapeutics for Parkinson’s Disease. International Journal of High School Research, 8(9), 182-192. https://doi.org/10.36838/ijhsr89.182
Vancouver
Winoto J. Bridging Metabolism and Neurodegeneration: Antidiabetic Drugs as Therapeutics for Parkinson’s Disease. International Journal of High School Research. 2026;8(9):182-192. doi:10.36838/ijhsr89.182
BibTeX
@article{Winoto2026,
author = {Winoto, Jeffrey},
title = {Bridging Metabolism and Neurodegeneration: Antidiabetic Drugs as Therapeutics for Parkinson’s Disease},
journal = {International Journal of High School Research},
year = {2026},
volume = {8},
number = {9},
pages = {182--192},
doi = {10.36838/ijhsr89.182}
}
EUVIMED